Dianthus Therapeutics Inc. (DNTH) stock news · rev $2.0M
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
This DNTH news page leads with what Dianthus Therapeutics Inc. filed — not a scraped headline mill.
No cached 8-K sentence for DNTH yet. We will not pad this page with generic market recap.
Latest reported DNTH revenue for 2025-12-31 was $2.0M. Net income was -$162.3M. Revenue was down 67.3% from 2024-12-31 to 2025-12-31. DNTH currently screens at market cap $4.40B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the DNTH stock page; for the tape open the quote page.
DNTH stock news FAQ
What are DNTH's latest revenue and net income?
Latest cached Dianthus Therapeutics Inc. (DNTH) revenue for Dec 31, 2025 was $2.0M. Net income was -$162.3M. Statements: https://lician.com/financials/dnth
How did DNTH revenue change from the prior cached period?
Cached Dianthus Therapeutics Inc. (DNTH) revenue was down 67.3% from $6.2M (Dec 31, 2024) to $2.0M (Dec 31, 2025). Statements: https://lician.com/financials/dnth
What is DNTH's market cap?
Dianthus Therapeutics Inc. (DNTH) market cap is $4.40B on the latest cached fundamentals snapshot.
What kind of company is DNTH?
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Where is DNTH stock news listed?
Cached stock news for Dianthus Therapeutics Inc. (DNTH) is listed at https://lician.com/news/dnth. Filings: https://lician.com/sec/dnth
Not investment advice.